194 related articles for article (PubMed ID: 16714840)
1. Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus.
Iwasaki T; Nakajima A; Yoneda M; Terauchi Y
Endocr J; 2006 Jun; 53(3):345-56. PubMed ID: 16714840
[TBL] [Abstract][Full Text] [Related]
2. Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance.
Iwasaki T; Yoneda M; Nakajima A; Terauchi Y
Intern Med; 2007; 46(19):1633-9. PubMed ID: 17917325
[TBL] [Abstract][Full Text] [Related]
3. Serum ferritin is associated with visceral fat area and subcutaneous fat area.
Iwasaki T; Nakajima A; Yoneda M; Yamada Y; Mukasa K; Fujita K; Fujisawa N; Wada K; Terauchi Y
Diabetes Care; 2005 Oct; 28(10):2486-91. PubMed ID: 16186284
[TBL] [Abstract][Full Text] [Related]
4. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients.
Taniguchi A; Nakai Y; Sakai M; Yoshii S; Hamanaka D; Hatae Y; Kawata M; Yamanouchi K; Okumura T; Doi K; Tokuyama K; Nagasaka S; Fukushima M
Metabolism; 2002 May; 51(5):544-8. PubMed ID: 11979383
[TBL] [Abstract][Full Text] [Related]
5. Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients.
Park JS; Cho MH; Nam JS; Ahn CW; Cha BS; Lee EJ; Lim SK; Kim KR; Lee HC
Acta Diabetol; 2010 Jun; 47(2):113-8. PubMed ID: 19415164
[TBL] [Abstract][Full Text] [Related]
6. Effects of liraglutide, a human glucagon-like peptide-1 analogue, on body weight, body fat area and body fat-related markers in patients with type 2 diabetes mellitus.
Suzuki D; Toyoda M; Kimura M; Miyauchi M; Yamamoto N; Sato H; Tanaka E; Kuriyama Y; Miyatake H; Abe M; Umezono T; Fukagawa M
Intern Med; 2013; 52(10):1029-34. PubMed ID: 23676586
[TBL] [Abstract][Full Text] [Related]
7. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
8. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients.
Gohda T; Gotoh H; Tanimoto M; Sato M; Io H; Kaneko K; Hamada C; Tomino Y
Hypertens Res; 2008 Jan; 31(1):83-8. PubMed ID: 18360022
[TBL] [Abstract][Full Text] [Related]
9. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus.
Yatagai T; Nagasaka S; Taniguchi A; Fukushima M; Nakamura T; Kuroe A; Nakai Y; Ishibashi S
Metabolism; 2003 Oct; 52(10):1274-8. PubMed ID: 14564678
[TBL] [Abstract][Full Text] [Related]
10. High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes.
Bouchi R; Takeuchi T; Akihisa M; Ohara N; Nakano Y; Nishitani R; Murakami M; Fukuda T; Fujita M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
Cardiovasc Diabetol; 2015 Oct; 14():136. PubMed ID: 26445876
[TBL] [Abstract][Full Text] [Related]
11. Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects.
Obata Y; Maeda N; Yamada Y; Yamamoto K; Nakamura S; Yamaoka M; Tanaka Y; Masuda S; Nagao H; Fukuda S; Fujishima Y; Kita S; Nishizawa H; Funahashi T; Matsubara KI; Matsuzawa Y; Shimomura I
Cardiovasc Diabetol; 2016 Nov; 15(1):159. PubMed ID: 27899146
[TBL] [Abstract][Full Text] [Related]
12. Effects of Aging on Visceral and Subcutaneous Fat Areas and on Homeostasis Model Assessment of Insulin Resistance and Insulin Secretion Capacity in a Comprehensive Health Checkup.
Hirose H; Takayama M; Iwao Y; Kawabe H
J Atheroscler Thromb; 2016; 23(2):207-15. PubMed ID: 26412583
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.
Putz DM; Goldner WS; Bar RS; Haynes WG; Sivitz WI
Metabolism; 2004 Nov; 53(11):1454-61. PubMed ID: 15536601
[TBL] [Abstract][Full Text] [Related]
14. Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type.
Miyazaki Y; DeFronzo RA
Cardiovasc Diabetol; 2009 Aug; 8():44. PubMed ID: 19656356
[TBL] [Abstract][Full Text] [Related]
15. Association of subcutaneous and visceral fat mass with serum concentrations of adipokines in subjects with type 2 diabetes mellitus.
Saito T; Murata M; Otani T; Tamemoto H; Kawakami M; Ishikawa SE
Endocr J; 2012; 59(1):39-45. PubMed ID: 22019947
[TBL] [Abstract][Full Text] [Related]
16. High serum levels of C-reactive protein (CRP) predict beneficial decrease of visceral fat in obese females after sleeve gastrectomy.
Carbone F; Nulli Migliola E; Bonaventura A; Vecchié A; De Vuono S; Ricci MA; Vaudo G; Boni M; Dallegri F; Montecucco F; Lupattelli G
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):494-500. PubMed ID: 29502925
[TBL] [Abstract][Full Text] [Related]
17. Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults.
Kim K; Valentine RJ; Shin Y; Gong K
Metabolism; 2008 Sep; 57(9):1181-9. PubMed ID: 18702942
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women.
Baek J; Jung SJ; Shim JS; Jeon YW; Seo E; Kim HC
J Prev Med Public Health; 2020 Jul; 53(4):256-265. PubMed ID: 32752595
[TBL] [Abstract][Full Text] [Related]
19. Relationships between Composition of Major Fatty Acids and Fat Distribution and Insulin Resistance in Japanese.
Fujii C; Kawai T; Azuma K; Oguma Y; Katsukawa F; Hirose H; Tanaka K; Meguro S; Matsumoto H; Itoh H
J Diabetes Res; 2017; 2017():1567467. PubMed ID: 28540308
[No Abstract] [Full Text] [Related]
20. Plasma Bile Acids More Closely Align With Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity.
Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1131-e1139. PubMed ID: 33347566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
